Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000016

Chief Scientific Officer sold 50,000 shares at an average $32.62 ($1,631,037)

  • Chief Scientific Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-09 Exercise or conversion : show line 1 in the form +26,705 $26.49 $707,415 259,255 D
2021-07-09 Sale : show line 2 in the form −26,705 $32.79 $875,657 232,550 D
2021-07-09 Exercise or conversion : show line 3 in the form +5,603 $26.49 $148,423 238,153 D
2021-07-09 Sale : show line 4 in the form −5,603 $32.29 $180,921 232,550 D
2021-07-09 Exercise or conversion : show line 5 in the form +17,692 $19.47 $344,463 250,242 D
2021-07-09 Sale : show line 6 in the form −17,692 $32.47 $574,459 232,550 D
Open-market sales · 50,000 sh · avg $32.62 · $1,631,037

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-07-09 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) −17,692 0 D
2021-07-09 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) −26,705 115,123 D
2021-07-09 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) −5,603 109,520 D
Loading xslF345X03/edgardoc.xml…